Javascript must be enabled to continue!
David Ben-Gurion
View through CrossRef
This chapter concentrates on the first Israeli prime minister, David Ben-Gurion (1886–1973), and traces the continuum of his positions about the issue of Jewish national self-determination from before World War I until after the Holocaust. Before World War I, Ben-Gurion wholeheartedly supported the continued existence of the Ottoman Empire on the basis of a revised multinational blueprint that was based on his own assessment of “what is good for the Jewish people.” Furthermore, Ben-Gurion copied the idea of “decentralization” from the Ottoman context and made it a part of his vision for the future character of the Jewish state in Palestine as supported by him throughout most of the Mandate period.
Title: David Ben-Gurion
Description:
This chapter concentrates on the first Israeli prime minister, David Ben-Gurion (1886–1973), and traces the continuum of his positions about the issue of Jewish national self-determination from before World War I until after the Holocaust.
Before World War I, Ben-Gurion wholeheartedly supported the continued existence of the Ottoman Empire on the basis of a revised multinational blueprint that was based on his own assessment of “what is good for the Jewish people.
” Furthermore, Ben-Gurion copied the idea of “decentralization” from the Ottoman context and made it a part of his vision for the future character of the Jewish state in Palestine as supported by him throughout most of the Mandate period.
Related Results
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
IMPORTANCE
Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19.
...
The Joshua Study Group at the Home of David Ben-Gurion
The Joshua Study Group at the Home of David Ben-Gurion
This chapter talks about “The Joshua Study Group at the Home of David Ben-Gurion,” which invited leading minds in Israel into Prime Minister David Ben-Gurion's home to ponder toget...
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing in Africa over the past year has led to a major increase in the number of sequences that have ...
Intravenous Vitamin C for Patients Hospitalized With COVID-19
Intravenous Vitamin C for Patients Hospitalized With COVID-19
ImportanceThe efficacy of vitamin C for hospitalized patients with COVID-19 is uncertain.ObjectiveTo determine whether vitamin C improves outcomes for patients with COVID-19.Design...
Mobbing 2.0
Mobbing 2.0
Ben geht in die achte Klasse eines Gymnasiums in einer Kleinstadt. Und er geht ungern. Denn Ben ist ein Außenseiter, der von seinen Klassenkameraden wie Luft behandelt wird – wenn ...
Genomic reconstruction of the SARS-CoV-2 epidemic in England
Genomic reconstruction of the SARS-CoV-2 epidemic in England
Abstract
The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus leads to new variants that warrant timely epidemiological charact...
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Importance
The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown.
...

